J. Goldman & Co’s Chemours CC Stock Holding History

J. Goldman & Co’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-34,000	Closed	-$749K	–	730
2026 Q1	$749K	Buy	+34,000	New	+$592K	0.02%	456
2016 Q2	–	Sell	-7,300	Closed	-$51K	–	336
2016 Q1	$51K	Buy	+7,300	New	+$36.7K	﹤0.01%	281

Other funds holding CC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCPM

Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

J. Goldman & Co's CC Position: Q2 2026 in Review

J. Goldman & Co sold out of Chemours (CC) in Q2 2026, closing a stake of 34,000 shares — an estimated $749K sold.

J. Goldman & Co first reported a position in CC in Q1 2016 and held it in 2 quarters. The position peaked at $749K in Q1 2026. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.

J. Goldman & Co reported no remaining Chemours position as of Q2 2026 after selling out during the quarter.
J. Goldman & Co sold 34,000 Chemours shares in Q2 2026, an estimated $749K.
J. Goldman & Co first reported a position in Chemours in Q1 2016 and held it in 2 quarters.
J. Goldman & Co's Chemours position peaked at $749K in Q1 2026.
469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on J. Goldman & Co's 13F filing for Q2 2026, filed 14 Aug 2026.